Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries

Simple item page
buir.contributor.authorWigley, Simon Drummond
buir.contributor.orcidWigley, Simon Drummond|0000-0001-9181-0129
dc.citation.epage8en_US
dc.citation.spage1en_US
dc.citation.volumeNumber297en_US
dc.contributor.authorAllen, Luke N.
dc.contributor.authorWigley, Simon Drummond
dc.contributor.authorHolmer, Hampus
dc.date.accessioned2023-02-27T10:11:59Z
dc.date.available2023-02-27T10:11:59Z
dc.date.issued2021-02-22
dc.departmentDepartment of Philosophyen_US
dc.description.abstractObjective: Non-communicable diseases (NCDs) are the leading cause of global death and disability. Tobacco, alcohol, and unhealthy foods are major contributing risk factors. WHO Member States have unanimously endorsed a set of 12 policies designed to constrain the sale of these commodities, however, there are myriad case studies of commercial entities seeking to undermine effective legislation in order to protect their profits. We set out to quantify the association between corporate financial influence and implementation of commercial policies. Methods: We generated policy implementation scores for all 194 WHO Member States using data from the 2015, 2017, and 2020 WHO NCD Progress Monitor Reports. We used publicly available data to create a novel Corporate Financial Influence Index (CFII) that quantifies the opportunity for corporations to use their financial resources to directly influence policymaking in each country. We reported policy implementation trends over time and used random effects multivariate regression to test the association between policy implementation and CFII for each country, while controlling for broad set of economic, cultural, historical, geographic, and demographic factors. Findings: Implementation of the 12 WHO-backed commercial policies has risen over time, but remains low at approximately 40%. Progress is reversing for alcohol policies. CFII explains around a fifth of the variance in global implementation. For every 10% rise in CFII, implementation falls by approximately 2% (95%CI 0.90 to 3.5, p < 0.001). Conclusion: Our quantitative global analysis suggests that financial corporate influence is negatively associated with implementation of policies that seek to restrict the marketing, sale, and consumption of unhealthy (but profitable) commodities. In the context of anemic international progress tackling NCDs, greater attention should be paid to managing regulatory opportunities for overt and covert corporate financial influence as a core plank of the global NCD response. © 2022 The Authorsen_US
dc.identifier.doi10.1016/j.socscimed.2022.114825en_US
dc.identifier.issn02779536
dc.identifier.urihttp://hdl.handle.net/11693/111807
dc.language.isoEnglishen_US
dc.publisherElsevier Ltden_US
dc.relation.isversionofhttps://dx.doi.org/10.1016/j.socscimed.2022.114825en_US
dc.source.titleSocial Science and Medicineen_US
dc.subjectAlcoholen_US
dc.subjectCommercial determinants of healthen_US
dc.subjectDieten_US
dc.subjectGlobal healthen_US
dc.subjectHealth policyen_US
dc.subjectNon-communicable diseasesen_US
dc.subjectTobaccoen_US
dc.titleAssessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countriesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Assessing_the_association_between_Corporate_Financial_Influence_and_implementation_of_policies_to_tackle_commercial_determinants_of_non-communicable_diseases_A_cross-sectional_analysis_of_172_countries.pdf
Size:
1.78 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Department of Philosophy